meta-reg-snw-52
Interacting subnets
| Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
|---|---|---|---|---|---|---|---|
| int-snw-1120 | tai-screen-luciferase | 6.205 | 8.63e-128 | 1.09e-06 | 4.18e-03 | 23 | 17 |
| reg-snw-52 | tai-screen-luciferase | 4.903 | 9.49e-27 | 2.11e-04 | 3.66e-04 | 9 | 6 |
| int-snw-56848 | tai-screen-luciferase | 6.375 | 2.94e-136 | 3.59e-07 | 2.58e-03 | 24 | 19 |
| int-snw-10296 | tai-screen-luciferase | 6.413 | 3.70e-138 | 2.79e-07 | 2.32e-03 | 18 | 15 |
| int-snw-5714 | tai-screen-luciferase | 6.408 | 6.16e-138 | 2.88e-07 | 2.35e-03 | 16 | 13 |
| int-snw-51382 | tai-screen-luciferase | 7.286 | 3.65e-186 | 4.21e-10 | 1.27e-04 | 13 | 12 |
| int-snw-51741 | tai-screen-luciferase | 6.174 | 2.67e-126 | 1.32e-06 | 4.54e-03 | 24 | 19 |
| int-snw-5706 | tai-screen-luciferase | 6.189 | 4.80e-127 | 1.20e-06 | 4.35e-03 | 25 | 21 |
Genes (49)
| Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
|---|---|---|---|---|---|---|---|
| RPS20 | 6224 | 22 | -4.757 | 6.314 | 153 | Yes | - |
| RPS8 | 6202 | 33 | -5.545 | 7.555 | 234 | - | - |
| MAPK8 | 5599 | 28 | -4.403 | 6.468 | 153 | - | - |
| CHMP2A | 27243 | 33 | -9.037 | 7.555 | 41 | Yes | Yes |
| RPS15 | 6209 | 30 | -5.040 | 7.011 | 116 | Yes | - |
| COPA | 1314 | 48 | -9.395 | 5.672 | 340 | Yes | Yes |
| RNF20 | 56254 | 28 | -4.564 | 6.174 | 18 | - | - |
| HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | - | Yes |
| CHKB | 1120 | 8 | -2.194 | 6.205 | 42 | - | - |
| SRC | 6714 | 28 | -2.806 | 6.174 | 419 | Yes | - |
| COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | Yes | Yes |
| CKAP5 | 9793 | 46 | -7.214 | 5.672 | 130 | Yes | Yes |
| EIF2S2 | 8894 | 31 | -4.320 | 5.672 | 103 | Yes | - |
| RPS16 | 6217 | 38 | -5.444 | 4.880 | 205 | - | - |
| PSMD1 | 5707 | 16 | -3.604 | 6.408 | 113 | - | Yes |
| CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | Yes | Yes |
| MAEA | 10296 | 13 | -2.793 | 6.413 | 43 | - | - |
| RPS11 | 6205 | 44 | -6.588 | 7.555 | 175 | Yes | - |
| ARL1 | 400 | 18 | -4.142 | 8.046 | 110 | - | Yes |
| RPS6 | 6194 | 44 | -5.603 | 8.046 | 217 | Yes | - |
| MRPS12 | 6183 | 35 | -5.421 | 5.516 | 341 | Yes | - |
| TLK2 | 11011 | 21 | -4.011 | 5.672 | 14 | - | - |
| RAN | 5901 | 38 | -3.809 | 4.325 | 258 | Yes | Yes |
| UBB | 7314 | 30 | -4.289 | 6.428 | 147 | - | - |
| COPB1 | 1315 | 39 | -6.221 | 9.063 | 118 | Yes | Yes |
| RPS13 | 6207 | 43 | -6.589 | 7.555 | 174 | Yes | - |
| CDC5L | 988 | 34 | -3.419 | 5.672 | 155 | - | - |
| SRPK2 | 6733 | 10 | -2.827 | 4.940 | 109 | - | - |
| PLK1 | 5347 | 14 | -3.690 | 6.189 | 217 | Yes | - |
| RPS24 | 6229 | 46 | -7.034 | 8.389 | 217 | Yes | - |
| TCERG1 | 10915 | 28 | -3.808 | 6.174 | 58 | Yes | - |
| RPS9 | 6203 | 45 | -7.127 | 7.555 | 140 | Yes | - |
| RPS4X | 6191 | 44 | -6.747 | 7.555 | 263 | Yes | - |
| COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | Yes | Yes |
| ATP6V1D | 51382 | 30 | -4.131 | 7.286 | 149 | - | - |
| RPS15A | 6210 | 36 | -5.413 | 7.555 | 177 | Yes | - |
| WDR46 | 9277 | 31 | -4.290 | 4.226 | 101 | Yes | Yes |
| WWOX | 51741 | 28 | -2.448 | 6.174 | 38 | - | - |
| RPS27A | 6233 | 45 | -5.631 | 8.389 | 344 | Yes | - |
| PSMC6 | 5706 | 14 | -3.169 | 6.408 | 158 | - | - |
| PSMD3 | 5709 | 22 | -3.935 | 6.408 | 201 | - | Yes |
| PSMD8 | 5714 | 15 | -2.916 | 4.418 | 143 | - | - |
| SKP1 | 6500 | 26 | -3.750 | 6.413 | 203 | - | - |
| ACP1 | 52 | 8 | -2.230 | 4.903 | 46 | - | - |
| NFKBIB | 4793 | 28 | -3.978 | 6.174 | 78 | - | - |
| SPHK2 | 56848 | 17 | -3.010 | 6.375 | 37 | - | - |
| RPS26 | 6231 | 43 | -7.478 | 8.046 | 60 | Yes | - |
| ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | Yes | Yes |
| SRPK1 | 6732 | 8 | -3.733 | 7.138 | 50 | - | - |
Interactions (134)
| Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
|---|---|---|---|---|---|---|
| CDC42 | 998 | RPS27A | 6233 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
| RPS20 | 6224 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
| RPS4X | 6191 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS27A | 6233 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
| RPS11 | 6205 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
| RPS11 | 6205 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD1 | 5707 | PSMD8 | 5714 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, YeastMedium, Krogan_Core, MINT_Yeast |
| TCERG1 | 10915 | WWOX | 51741 | pp | -- | int.I2D: BioGrid, MINT, Pawson1; int.Mint: MI:0915(physical association) |
| EIF2S2 | 8894 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
| COPA | 1314 | PSMD8 | 5714 | pp | -- | int.I2D: YeastLow |
| RPS13 | 6207 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD1 | 5707 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Krogan_Core |
| SRPK1 | 6732 | TCERG1 | 10915 | pd | < | reg.ITFP.txt: no annot |
| PLK1 | 5347 | PSMC6 | 5706 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
| SRC | 6714 | CKAP5 | 9793 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
| ARCN1 | 372 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
| CDC42 | 998 | UBB | 7314 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
| NFKBIB | 4793 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| RPS15 | 6209 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS8 | 6202 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
| ACP1 | 52 | MRPS12 | 6183 | pd | < | reg.ITFP.txt: no annot |
| RPS9 | 6203 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS8 | 6202 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS16 | 6217 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| MRPS12 | 6183 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium |
| SKP1 | 6500 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| RPS13 | 6207 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS15 | 6209 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
| RPS11 | 6205 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
| RPS13 | 6207 | WDR46 | 9277 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS6 | 6194 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
| CHKB | 1120 | SRPK2 | 6733 | pp | -- | int.I2D: BioGrid_Yeast, Yeast_Kinome |
| PLK1 | 5347 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
| RPS9 | 6203 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
| CHKB | 1120 | PSMD3 | 5709 | pp | -- | int.I2D: IntAct_Yeast |
| UBB | 7314 | WWOX | 51741 | pp | -- | int.I2D: BCI, HPRD; int.HPRD: in vivo |
| UBB | 7314 | RNF20 | 56254 | pp | -- | int.Intact: MI:0220(ubiquitination reaction); int.I2D: IntAct |
| MRPS12 | 6183 | RPS15 | 6209 | pp | -- | int.I2D: YeastMedium |
| RPS8 | 6202 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS15A | 6210 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| ARL1 | 400 | CHKB | 1120 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS11 | 6205 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS8 | 6202 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| SRC | 6714 | WWOX | 51741 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
| RPS16 | 6217 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMC6 | 5706 | PSMD8 | 5714 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
| RPS15A | 6210 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastHigh, YeastMedium |
| MAEA | 10296 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
| ARL1 | 400 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD1 | 5707 | SRPK2 | 6733 | pp | -- | int.I2D: BioGrid_Yeast, Yeast_Kinome |
| RPS20 | 6224 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
| RPS27A | 6233 | UBB | 7314 | pp | -- | int.I2D: BIND |
| PSMD3 | 5709 | PSMD8 | 5714 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, IntAct_Yeast, INTEROLOG, Krogan_Core, YeastHigh |
| RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| ARL1 | 400 | COPA | 1314 | pp | -- | int.I2D: BioGrid_Yeast |
| RAN | 5901 | RPS15 | 6209 | pp | -- | int.I2D: YeastLow |
| RPS4X | 6191 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium, INTEROLOG |
| RPS8 | 6202 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS6 | 6194 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
| RPS8 | 6202 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS6 | 6194 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
| COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
| PSMC6 | 5706 | SKP1 | 6500 | pp | -- | int.I2D: YeastLow |
| PSMD8 | 5714 | MRPS12 | 6183 | pd | < | reg.ITFP.txt: no annot |
| RPS8 | 6202 | CHMP2A | 27243 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS24 | 6229 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
| CDC5L | 988 | CKAP5 | 9793 | pd | <> | reg.ITFP.txt: no annot |
| RAN | 5901 | WDR46 | 9277 | pp | -- | int.I2D: YeastLow |
| PSMD8 | 5714 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
| PLK1 | 5347 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| ACP1 | 52 | CDC5L | 988 | pd | < | reg.ITFP.txt: no annot |
| HSF1 | 3297 | MAPK8 | 5599 | pp | -- | int.I2D: HPRD, INNATEDB; int.HPRD: in vitro, in vivo |
| COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
| NFKBIB | 4793 | SKP1 | 6500 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vitro |
| PSMC6 | 5706 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
| PSMC6 | 5706 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh |
| COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
| COPA | 1314 | SRPK2 | 6733 | pd | > | reg.ITFP.txt: no annot |
| COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
| PLK1 | 5347 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Fly, FlyEmbryo, IntAct_Fly |
| COPA | 1314 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
| RPS15 | 6209 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
| RPS4X | 6191 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS15A | 6210 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
| CDC5L | 988 | TLK2 | 11011 | pd | > | reg.ITFP.txt: no annot |
| RPS13 | 6207 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
| ARCN1 | 372 | ARL1 | 400 | pp | -- | int.I2D: BioGrid_Yeast |
| ARL1 | 400 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
| HSF1 | 3297 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
| RAN | 5901 | SPHK2 | 56848 | pp | -- | int.I2D: IntAct_Yeast, BIND_Yeast, MINT_Yeast, MIPS, YeastLow |
| RPS4X | 6191 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
| CDC5L | 988 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
| CDC5L | 988 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
| COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
| ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
| RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS15 | 6209 | RPS15A | 6210 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
| RPS6 | 6194 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMC6 | 5706 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
| SRPK1 | 6732 | SRPK2 | 6733 | pp | -- | int.I2D: BioGrid, MINT |
| RPS6 | 6194 | RPS20 | 6224 | pp | -- | int.I2D: YeastLow |
| ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
| PSMC6 | 5706 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid_Yeast, Krogan_Core, MINT_Yeast |
| RPS6 | 6194 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
| CDC5L | 988 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid |
| COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
| MAPK8 | 5599 | WWOX | 51741 | pp | -- | int.I2D: MINT, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
| RPS8 | 6202 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS16 | 6217 | RPS26 | 6231 | pp | -- | int.I2D: BioGrid_Yeast |
| RAN | 5901 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
| RPS15A | 6210 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
| ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
| RAN | 5901 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS11 | 6205 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
| PSMC6 | 5706 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
| RPS13 | 6207 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS24 | 6229 | RPS27A | 6233 | pp | -- | int.I2D: YeastMedium |
| PSMD3 | 5709 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
| RPS8 | 6202 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
Related GO terms (572)
| Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
|---|---|---|---|---|---|---|---|
| GO:0022627 | cytosolic small ribosomal subunit | 2.17e-24 | 3.54e-20 | 6.795 | 13 | 21 | 39 |
| GO:0019058 | viral life cycle | 3.45e-23 | 5.63e-19 | 5.534 | 16 | 25 | 115 |
| GO:0016032 | viral process | 5.24e-23 | 8.55e-19 | 3.888 | 24 | 37 | 540 |
| GO:0016071 | mRNA metabolic process | 1.09e-21 | 1.79e-17 | 4.749 | 18 | 29 | 223 |
| GO:0016070 | RNA metabolic process | 7.08e-21 | 1.16e-16 | 4.601 | 18 | 29 | 247 |
| GO:0005829 | cytosol | 1.83e-20 | 2.99e-16 | 2.266 | 37 | 74 | 2562 |
| GO:0019083 | viral transcription | 9.20e-20 | 1.50e-15 | 5.740 | 13 | 22 | 81 |
| GO:0006415 | translational termination | 2.48e-19 | 4.04e-15 | 5.637 | 13 | 22 | 87 |
| GO:0006414 | translational elongation | 6.21e-19 | 1.01e-14 | 5.541 | 13 | 22 | 93 |
| GO:0006413 | translational initiation | 1.20e-18 | 1.96e-14 | 5.154 | 14 | 27 | 131 |
| GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 2.86e-18 | 4.67e-14 | 5.380 | 13 | 22 | 104 |
| GO:0003735 | structural constituent of ribosome | 3.48e-18 | 5.68e-14 | 5.048 | 14 | 24 | 141 |
| GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9.92e-18 | 1.62e-13 | 5.247 | 13 | 22 | 114 |
| GO:0006412 | translation | 1.54e-16 | 2.52e-12 | 4.410 | 15 | 29 | 235 |
| GO:0010467 | gene expression | 1.26e-15 | 2.05e-11 | 3.316 | 20 | 36 | 669 |
| GO:0015935 | small ribosomal subunit | 2.67e-14 | 4.36e-10 | 7.100 | 7 | 9 | 17 |
| GO:0044822 | poly(A) RNA binding | 7.88e-14 | 1.29e-09 | 2.765 | 22 | 42 | 1078 |
| GO:0016020 | membrane | 2.43e-13 | 3.97e-09 | 2.310 | 26 | 48 | 1746 |
| GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.97e-11 | 4.85e-07 | 5.250 | 8 | 8 | 70 |
| GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.70e-11 | 7.68e-07 | 5.170 | 8 | 8 | 74 |
| GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.05e-11 | 1.31e-06 | 5.076 | 8 | 8 | 79 |
| GO:0044267 | cellular protein metabolic process | 1.18e-10 | 1.93e-06 | 3.236 | 14 | 29 | 495 |
| GO:0048205 | COPI coating of Golgi vesicle | 2.50e-10 | 4.08e-06 | 7.001 | 5 | 6 | 13 |
| GO:0030126 | COPI vesicle coat | 2.50e-10 | 4.08e-06 | 7.001 | 5 | 6 | 13 |
| GO:0061024 | membrane organization | 4.34e-10 | 7.08e-06 | 4.360 | 9 | 11 | 146 |
| GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.00e-08 | 1.64e-04 | 6.058 | 5 | 6 | 25 |
| GO:0000082 | G1/S transition of mitotic cell cycle | 1.38e-08 | 2.26e-04 | 4.151 | 8 | 11 | 150 |
| GO:0042274 | ribosomal small subunit biogenesis | 3.49e-08 | 5.69e-04 | 6.795 | 4 | 6 | 12 |
| GO:0070062 | extracellular vesicular exosome | 3.58e-08 | 5.83e-04 | 1.668 | 24 | 51 | 2516 |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.85e-08 | 6.29e-04 | 4.942 | 6 | 6 | 65 |
| GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.85e-08 | 6.29e-04 | 4.942 | 6 | 6 | 65 |
| GO:0043066 | negative regulation of apoptotic process | 4.74e-08 | 7.74e-04 | 3.081 | 11 | 14 | 433 |
| GO:0000209 | protein polyubiquitination | 5.12e-08 | 8.36e-04 | 4.329 | 7 | 7 | 116 |
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.80e-08 | 1.27e-03 | 4.775 | 6 | 6 | 73 |
| GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.08e-07 | 1.76e-03 | 4.698 | 6 | 6 | 77 |
| GO:0022624 | proteasome accessory complex | 1.66e-07 | 2.71e-03 | 6.292 | 4 | 4 | 17 |
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.56e-07 | 5.81e-03 | 4.410 | 6 | 7 | 94 |
| GO:0000278 | mitotic cell cycle | 2.41e-06 | 3.94e-02 | 2.913 | 9 | 16 | 398 |
| GO:0005838 | proteasome regulatory particle | 5.49e-06 | 8.96e-02 | 6.380 | 3 | 3 | 12 |
| GO:0042981 | regulation of apoptotic process | 5.72e-06 | 9.33e-02 | 3.726 | 6 | 7 | 151 |
| GO:0005925 | focal adhesion | 1.29e-05 | 2.11e-01 | 2.848 | 8 | 23 | 370 |
| GO:0042176 | regulation of protein catabolic process | 1.39e-05 | 2.26e-01 | 5.965 | 3 | 4 | 16 |
| GO:0006521 | regulation of cellular amino acid metabolic process | 1.49e-05 | 2.43e-01 | 4.736 | 4 | 5 | 50 |
| GO:0075733 | intracellular transport of virus | 1.68e-05 | 2.74e-01 | 5.877 | 3 | 3 | 17 |
| GO:0006891 | intra-Golgi vesicle-mediated transport | 1.68e-05 | 2.74e-01 | 5.877 | 3 | 3 | 17 |
| GO:0005515 | protein binding | 2.19e-05 | 3.57e-01 | 0.843 | 33 | 87 | 6127 |
| GO:0000056 | ribosomal small subunit export from nucleus | 2.64e-05 | 4.32e-01 | 7.795 | 2 | 2 | 3 |
| GO:0000502 | proteasome complex | 2.70e-05 | 4.41e-01 | 4.522 | 4 | 4 | 58 |
| GO:0005840 | ribosome | 2.89e-05 | 4.72e-01 | 4.497 | 4 | 10 | 59 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.76e-05 | 6.14e-01 | 5.505 | 3 | 5 | 22 |
| GO:0034146 | toll-like receptor 5 signaling pathway | 4.24e-05 | 6.92e-01 | 4.357 | 4 | 5 | 65 |
| GO:0034166 | toll-like receptor 10 signaling pathway | 4.24e-05 | 6.92e-01 | 4.357 | 4 | 5 | 65 |
| GO:0018105 | peptidyl-serine phosphorylation | 5.37e-05 | 8.76e-01 | 4.271 | 4 | 5 | 69 |
| GO:0000086 | G2/M transition of mitotic cell cycle | 5.49e-05 | 8.96e-01 | 3.604 | 5 | 6 | 137 |
| GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 6.01e-05 | 9.81e-01 | 4.230 | 4 | 5 | 71 |
| GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 6.01e-05 | 9.81e-01 | 4.230 | 4 | 5 | 71 |
| GO:0034162 | toll-like receptor 9 signaling pathway | 6.35e-05 | 1.00e+00 | 4.210 | 4 | 5 | 72 |
| GO:0034134 | toll-like receptor 2 signaling pathway | 6.70e-05 | 1.00e+00 | 4.190 | 4 | 5 | 73 |
| GO:0019843 | rRNA binding | 7.07e-05 | 1.00e+00 | 5.210 | 3 | 4 | 27 |
| GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 7.85e-05 | 1.00e+00 | 4.132 | 4 | 5 | 76 |
| GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 8.69e-05 | 1.00e+00 | 4.094 | 4 | 5 | 78 |
| GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.78e-05 | 1.00e+00 | 7.058 | 2 | 3 | 5 |
| GO:0033119 | negative regulation of RNA splicing | 8.78e-05 | 1.00e+00 | 7.058 | 2 | 2 | 5 |
| GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 9.59e-05 | 1.00e+00 | 4.058 | 4 | 5 | 80 |
| GO:0034138 | toll-like receptor 3 signaling pathway | 9.59e-05 | 1.00e+00 | 4.058 | 4 | 5 | 80 |
| GO:0048024 | regulation of mRNA splicing, via spliceosome | 1.31e-04 | 1.00e+00 | 6.795 | 2 | 2 | 6 |
| GO:0006886 | intracellular protein transport | 1.65e-04 | 1.00e+00 | 3.267 | 5 | 6 | 173 |
| GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.69e-04 | 1.00e+00 | 4.795 | 3 | 3 | 36 |
| GO:0034142 | toll-like receptor 4 signaling pathway | 1.94e-04 | 1.00e+00 | 3.795 | 4 | 5 | 96 |
| GO:0006364 | rRNA processing | 1.94e-04 | 1.00e+00 | 3.795 | 4 | 8 | 96 |
| GO:0002224 | toll-like receptor signaling pathway | 3.16e-04 | 1.00e+00 | 3.612 | 4 | 5 | 109 |
| GO:0005654 | nucleoplasm | 3.23e-04 | 1.00e+00 | 1.742 | 11 | 26 | 1095 |
| GO:0030529 | ribonucleoprotein complex | 3.75e-04 | 1.00e+00 | 3.547 | 4 | 8 | 114 |
| GO:0045087 | innate immune response | 4.52e-04 | 1.00e+00 | 2.113 | 8 | 11 | 616 |
| GO:0007254 | JNK cascade | 4.79e-04 | 1.00e+00 | 4.292 | 3 | 3 | 51 |
| GO:0051403 | stress-activated MAPK cascade | 5.66e-04 | 1.00e+00 | 4.210 | 3 | 4 | 54 |
| GO:0019082 | viral protein processing | 5.72e-04 | 1.00e+00 | 5.795 | 2 | 2 | 12 |
| GO:0032479 | regulation of type I interferon production | 6.74e-04 | 1.00e+00 | 5.679 | 2 | 2 | 13 |
| GO:0030234 | enzyme regulator activity | 6.74e-04 | 1.00e+00 | 5.679 | 2 | 2 | 13 |
| GO:0016197 | endosomal transport | 6.99e-04 | 1.00e+00 | 4.107 | 3 | 3 | 58 |
| GO:0032481 | positive regulation of type I interferon production | 8.10e-04 | 1.00e+00 | 4.034 | 3 | 3 | 61 |
| GO:0051233 | spindle midzone | 9.04e-04 | 1.00e+00 | 5.473 | 2 | 2 | 15 |
| GO:0019068 | virion assembly | 1.17e-03 | 1.00e+00 | 5.292 | 2 | 2 | 17 |
| GO:0045070 | positive regulation of viral genome replication | 1.17e-03 | 1.00e+00 | 5.292 | 2 | 2 | 17 |
| GO:0005737 | cytoplasm | 1.31e-03 | 1.00e+00 | 0.882 | 22 | 65 | 3976 |
| GO:0043065 | positive regulation of apoptotic process | 1.34e-03 | 1.00e+00 | 2.604 | 5 | 6 | 274 |
| GO:0006915 | apoptotic process | 1.48e-03 | 1.00e+00 | 2.030 | 7 | 9 | 571 |
| GO:0043393 | regulation of protein binding | 1.62e-03 | 1.00e+00 | 5.058 | 2 | 2 | 20 |
| GO:0034641 | cellular nitrogen compound metabolic process | 1.94e-03 | 1.00e+00 | 2.912 | 4 | 5 | 177 |
| GO:0007220 | Notch receptor processing | 1.96e-03 | 1.00e+00 | 4.920 | 2 | 2 | 22 |
| GO:0045787 | positive regulation of cell cycle | 2.15e-03 | 1.00e+00 | 4.856 | 2 | 2 | 23 |
| GO:0051297 | centrosome organization | 2.15e-03 | 1.00e+00 | 4.856 | 2 | 2 | 23 |
| GO:0004674 | protein serine/threonine kinase activity | 2.37e-03 | 1.00e+00 | 2.416 | 5 | 6 | 312 |
| GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 2.53e-03 | 1.00e+00 | 4.736 | 2 | 2 | 25 |
| GO:0005844 | polysome | 2.53e-03 | 1.00e+00 | 4.736 | 2 | 2 | 25 |
| GO:0007173 | epidermal growth factor receptor signaling pathway | 2.55e-03 | 1.00e+00 | 2.802 | 4 | 5 | 191 |
| GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.74e-03 | 1.00e+00 | 4.679 | 2 | 2 | 26 |
| GO:0005978 | glycogen biosynthetic process | 2.74e-03 | 1.00e+00 | 4.679 | 2 | 2 | 26 |
| GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.74e-03 | 1.00e+00 | 4.679 | 2 | 2 | 26 |
| GO:0001649 | osteoblast differentiation | 2.90e-03 | 1.00e+00 | 3.395 | 3 | 3 | 95 |
| GO:0045184 | establishment of protein localization | 2.95e-03 | 1.00e+00 | 4.625 | 2 | 2 | 27 |
| GO:2001286 | regulation of caveolin-mediated endocytosis | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0071393 | cellular response to progesterone stimulus | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0035063 | nuclear speck organization | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0033176 | proton-transporting V-type ATPase complex | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0006669 | sphinganine-1-phosphate biosynthetic process | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0022605 | oogenesis stage | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0021691 | cerebellar Purkinje cell layer maturation | 3.00e-03 | 1.00e+00 | 8.380 | 1 | 1 | 1 |
| GO:0071456 | cellular response to hypoxia | 3.17e-03 | 1.00e+00 | 3.350 | 3 | 3 | 98 |
| GO:0005730 | nucleolus | 3.43e-03 | 1.00e+00 | 1.247 | 12 | 36 | 1684 |
| GO:0007346 | regulation of mitotic cell cycle | 3.64e-03 | 1.00e+00 | 4.473 | 2 | 3 | 30 |
| GO:0032480 | negative regulation of type I interferon production | 4.14e-03 | 1.00e+00 | 4.380 | 2 | 2 | 32 |
| GO:0045071 | negative regulation of viral genome replication | 4.66e-03 | 1.00e+00 | 4.292 | 2 | 2 | 34 |
| GO:0007067 | mitotic nuclear division | 5.03e-03 | 1.00e+00 | 2.528 | 4 | 7 | 231 |
| GO:0097190 | apoptotic signaling pathway | 5.08e-03 | 1.00e+00 | 3.107 | 3 | 3 | 116 |
| GO:0034332 | adherens junction organization | 5.21e-03 | 1.00e+00 | 4.210 | 2 | 4 | 36 |
| GO:0016301 | kinase activity | 5.50e-03 | 1.00e+00 | 4.170 | 2 | 2 | 37 |
| GO:0003713 | transcription coactivator activity | 5.67e-03 | 1.00e+00 | 2.479 | 4 | 6 | 239 |
| GO:0008481 | sphinganine kinase activity | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0071987 | WD40-repeat domain binding | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0060661 | submandibular salivary gland formation | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0017050 | D-erythro-sphingosine kinase activity | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0071338 | positive regulation of hair follicle cell proliferation | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0007092 | activation of mitotic anaphase-promoting complex activity | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0002176 | male germ cell proliferation | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0004103 | choline kinase activity | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0048822 | enucleate erythrocyte development | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0072422 | signal transduction involved in DNA damage checkpoint | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0010632 | regulation of epithelial cell migration | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0001672 | regulation of chromatin assembly or disassembly | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0090135 | actin filament branching | 6.00e-03 | 1.00e+00 | 7.380 | 1 | 1 | 2 |
| GO:0008284 | positive regulation of cell proliferation | 6.24e-03 | 1.00e+00 | 2.087 | 5 | 7 | 392 |
| GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 6.25e-03 | 1.00e+00 | 2.999 | 3 | 3 | 125 |
| GO:0007219 | Notch signaling pathway | 6.25e-03 | 1.00e+00 | 2.999 | 3 | 4 | 125 |
| GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 6.72e-03 | 1.00e+00 | 4.022 | 2 | 4 | 41 |
| GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.97e-03 | 1.00e+00 | 2.942 | 3 | 4 | 130 |
| GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 7.37e-03 | 1.00e+00 | 3.953 | 2 | 2 | 43 |
| GO:0005634 | nucleus | 7.59e-03 | 1.00e+00 | 0.666 | 23 | 66 | 4828 |
| GO:0043525 | positive regulation of neuron apoptotic process | 8.40e-03 | 1.00e+00 | 3.856 | 2 | 2 | 46 |
| GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0003161 | cardiac conduction system development | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0010997 | anaphase-promoting complex binding | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0090045 | positive regulation of deacetylase activity | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0035033 | histone deacetylase regulator activity | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:2000017 | positive regulation of determination of dorsal identity | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0051683 | establishment of Golgi localization | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 2 | 3 |
| GO:0006670 | sphingosine metabolic process | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0005850 | eukaryotic translation initiation factor 2 complex | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0004705 | JUN kinase activity | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0000942 | condensed nuclear chromosome outer kinetochore | 8.98e-03 | 1.00e+00 | 6.795 | 1 | 1 | 3 |
| GO:0048011 | neurotrophin TRK receptor signaling pathway | 8.99e-03 | 1.00e+00 | 2.287 | 4 | 5 | 273 |
| GO:0007030 | Golgi organization | 9.87e-03 | 1.00e+00 | 3.736 | 2 | 3 | 50 |
| GO:0010628 | positive regulation of gene expression | 1.01e-02 | 1.00e+00 | 2.746 | 3 | 4 | 149 |
| GO:0030666 | endocytic vesicle membrane | 1.14e-02 | 1.00e+00 | 3.625 | 2 | 2 | 54 |
| GO:0034191 | apolipoprotein A-I receptor binding | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0004305 | ethanolamine kinase activity | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0040038 | polar body extrusion after meiotic divisions | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0032463 | negative regulation of protein homooligomerization | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0051902 | negative regulation of mitochondrial depolarization | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0031062 | positive regulation of histone methylation | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0060684 | epithelial-mesenchymal cell signaling | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0070851 | growth factor receptor binding | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0051835 | positive regulation of synapse structural plasticity | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0090231 | regulation of spindle checkpoint | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0072384 | organelle transport along microtubule | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 2 | 4 |
| GO:0007258 | JUN phosphorylation | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0048664 | neuron fate determination | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0033503 | HULC complex | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0005198 | structural molecule activity | 1.20e-02 | 1.00e+00 | 2.652 | 3 | 5 | 159 |
| GO:0035092 | sperm chromatin condensation | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0031063 | regulation of histone deacetylation | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0031467 | Cul7-RING ubiquitin ligase complex | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0000055 | ribosomal large subunit export from nucleus | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.20e-02 | 1.00e+00 | 2.652 | 3 | 3 | 159 |
| GO:0033625 | positive regulation of integrin activation | 1.20e-02 | 1.00e+00 | 6.380 | 1 | 1 | 4 |
| GO:0043005 | neuron projection | 1.25e-02 | 1.00e+00 | 2.634 | 3 | 6 | 161 |
| GO:0006468 | protein phosphorylation | 1.27e-02 | 1.00e+00 | 1.834 | 5 | 6 | 467 |
| GO:0044281 | small molecule metabolic process | 1.38e-02 | 1.00e+00 | 1.211 | 9 | 16 | 1295 |
| GO:0038095 | Fc-epsilon receptor signaling pathway | 1.46e-02 | 1.00e+00 | 2.547 | 3 | 3 | 171 |
| GO:2000641 | regulation of early endosome to late endosome transport | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0036336 | dendritic cell migration | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0033033 | negative regulation of myeloid cell apoptotic process | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0035556 | intracellular signal transduction | 1.49e-02 | 1.00e+00 | 2.071 | 4 | 5 | 317 |
| GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0051385 | response to mineralocorticoid | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0050684 | regulation of mRNA processing | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0005826 | actomyosin contractile ring | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:1902188 | positive regulation of viral release from host cell | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0097300 | programmed necrotic cell death | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0071168 | protein localization to chromatin | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0031256 | leading edge membrane | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0031584 | activation of phospholipase D activity | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0009404 | toxin metabolic process | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0071803 | positive regulation of podosome assembly | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0046834 | lipid phosphorylation | 1.49e-02 | 1.00e+00 | 6.058 | 1 | 1 | 5 |
| GO:0007059 | chromosome segregation | 1.58e-02 | 1.00e+00 | 3.380 | 2 | 3 | 64 |
| GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1.58e-02 | 1.00e+00 | 3.380 | 2 | 2 | 64 |
| GO:0007049 | cell cycle | 1.60e-02 | 1.00e+00 | 2.497 | 3 | 4 | 177 |
| GO:0004672 | protein kinase activity | 1.63e-02 | 1.00e+00 | 2.489 | 3 | 4 | 178 |
| GO:0019904 | protein domain specific binding | 1.70e-02 | 1.00e+00 | 2.465 | 3 | 3 | 181 |
| GO:0031295 | T cell costimulation | 1.72e-02 | 1.00e+00 | 3.314 | 2 | 3 | 67 |
| GO:0003682 | chromatin binding | 1.77e-02 | 1.00e+00 | 1.996 | 4 | 4 | 334 |
| GO:0050847 | progesterone receptor signaling pathway | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0007143 | female meiotic division | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0002309 | T cell proliferation involved in immune response | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0045182 | translation regulator activity | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 2 | 6 |
| GO:0045056 | transcytosis | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0060789 | hair follicle placode formation | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0048554 | positive regulation of metalloenzyme activity | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0050792 | regulation of viral process | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0000974 | Prp19 complex | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 1 | 6 |
| GO:0006924 | activation-induced cell death of T cells | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 2 | 6 |
| GO:0005524 | ATP binding | 1.81e-02 | 1.00e+00 | 1.147 | 9 | 19 | 1354 |
| GO:0003729 | mRNA binding | 2.03e-02 | 1.00e+00 | 3.190 | 2 | 3 | 73 |
| GO:0010447 | response to acidic pH | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0060136 | embryonic process involved in female pregnancy | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0043497 | regulation of protein heterodimerization activity | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0050658 | RNA transport | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0007097 | nuclear migration | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 2 | 7 |
| GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0061512 | protein localization to cilium | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0003334 | keratinocyte development | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0000028 | ribosomal small subunit assembly | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 3 | 7 |
| GO:0034101 | erythrocyte homeostasis | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0010907 | positive regulation of glucose metabolic process | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0048193 | Golgi vesicle transport | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0030157 | pancreatic juice secretion | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0006657 | CDP-choline pathway | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0000930 | gamma-tubulin complex | 2.08e-02 | 1.00e+00 | 5.572 | 1 | 1 | 7 |
| GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 2.24e-02 | 1.00e+00 | 3.113 | 2 | 4 | 77 |
| GO:0003924 | GTPase activity | 2.30e-02 | 1.00e+00 | 2.299 | 3 | 6 | 203 |
| GO:0039702 | viral budding via host ESCRT complex | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0043114 | regulation of vascular permeability | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0045124 | regulation of bone resorption | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0051489 | regulation of filopodium assembly | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0033523 | histone H2B ubiquitination | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0007172 | signal complex assembly | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0003993 | acid phosphatase activity | 2.38e-02 | 1.00e+00 | 5.380 | 1 | 1 | 8 |
| GO:0071222 | cellular response to lipopolysaccharide | 2.46e-02 | 1.00e+00 | 3.040 | 2 | 4 | 81 |
| GO:0071732 | cellular response to nitric oxide | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 1 | 9 |
| GO:0034067 | protein localization to Golgi apparatus | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 1 | 9 |
| GO:0090136 | epithelial cell-cell adhesion | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 2 | 9 |
| GO:0047497 | mitochondrion transport along microtubule | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 1 | 9 |
| GO:0046628 | positive regulation of insulin receptor signaling pathway | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 1 | 9 |
| GO:0006184 | GTP catabolic process | 2.83e-02 | 1.00e+00 | 2.183 | 3 | 6 | 220 |
| GO:0050852 | T cell receptor signaling pathway | 2.87e-02 | 1.00e+00 | 2.920 | 2 | 2 | 88 |
| GO:0005798 | Golgi-associated vesicle | 2.96e-02 | 1.00e+00 | 5.058 | 1 | 1 | 10 |
| GO:0031274 | positive regulation of pseudopodium assembly | 2.96e-02 | 1.00e+00 | 5.058 | 1 | 2 | 10 |
| GO:0022407 | regulation of cell-cell adhesion | 2.96e-02 | 1.00e+00 | 5.058 | 1 | 1 | 10 |
| GO:0060047 | heart contraction | 2.96e-02 | 1.00e+00 | 5.058 | 1 | 1 | 10 |
| GO:0000187 | activation of MAPK activity | 2.99e-02 | 1.00e+00 | 2.888 | 2 | 3 | 90 |
| GO:0000922 | spindle pole | 3.05e-02 | 1.00e+00 | 2.872 | 2 | 5 | 91 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.11e-02 | 1.00e+00 | 1.500 | 5 | 9 | 589 |
| GO:0016363 | nuclear matrix | 3.11e-02 | 1.00e+00 | 2.856 | 2 | 4 | 92 |
| GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 1 | 11 |
| GO:0051895 | negative regulation of focal adhesion assembly | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 1 | 11 |
| GO:0045120 | pronucleus | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 1 | 11 |
| GO:2000573 | positive regulation of DNA biosynthetic process | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 2 | 11 |
| GO:0060065 | uterus development | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 1 | 11 |
| GO:0010390 | histone monoubiquitination | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 1 | 11 |
| GO:0035518 | histone H2A monoubiquitination | 3.25e-02 | 1.00e+00 | 4.920 | 1 | 2 | 11 |
| GO:0061136 | regulation of proteasomal protein catabolic process | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 1 | 12 |
| GO:0007051 | spindle organization | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 1 | 12 |
| GO:0043149 | stress fiber assembly | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 2 | 12 |
| GO:0043249 | erythrocyte maturation | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 1 | 12 |
| GO:1903543 | positive regulation of exosomal secretion | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 1 | 12 |
| GO:1901214 | regulation of neuron death | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 1 | 12 |
| GO:0031929 | TOR signaling | 3.83e-02 | 1.00e+00 | 4.679 | 1 | 1 | 13 |
| GO:0006646 | phosphatidylethanolamine biosynthetic process | 3.83e-02 | 1.00e+00 | 4.679 | 1 | 1 | 13 |
| GO:0005662 | DNA replication factor A complex | 3.83e-02 | 1.00e+00 | 4.679 | 1 | 1 | 13 |
| GO:0071398 | cellular response to fatty acid | 3.83e-02 | 1.00e+00 | 4.679 | 1 | 2 | 13 |
| GO:0060444 | branching involved in mammary gland duct morphogenesis | 3.83e-02 | 1.00e+00 | 4.679 | 1 | 1 | 13 |
| GO:0004143 | diacylglycerol kinase activity | 3.83e-02 | 1.00e+00 | 4.679 | 1 | 1 | 13 |
| GO:0035371 | microtubule plus-end | 4.12e-02 | 1.00e+00 | 4.572 | 1 | 1 | 14 |
| GO:0031333 | negative regulation of protein complex assembly | 4.12e-02 | 1.00e+00 | 4.572 | 1 | 1 | 14 |
| GO:0050662 | coenzyme binding | 4.12e-02 | 1.00e+00 | 4.572 | 1 | 1 | 14 |
| GO:0017016 | Ras GTPase binding | 4.12e-02 | 1.00e+00 | 4.572 | 1 | 1 | 14 |
| GO:0071480 | cellular response to gamma radiation | 4.12e-02 | 1.00e+00 | 4.572 | 1 | 1 | 14 |
| GO:0031996 | thioesterase binding | 4.12e-02 | 1.00e+00 | 4.572 | 1 | 1 | 14 |
| GO:0030496 | midbody | 4.24e-02 | 1.00e+00 | 2.612 | 2 | 4 | 109 |
| GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:0048477 | oogenesis | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:0030131 | clathrin adaptor complex | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:0030225 | macrophage differentiation | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:0003951 | NAD+ kinase activity | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:0048821 | erythrocyte development | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 2 | 15 |
| GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 1 | 15 |
| GO:0031369 | translation initiation factor binding | 4.41e-02 | 1.00e+00 | 4.473 | 1 | 2 | 15 |
| GO:0015630 | microtubule cytoskeleton | 4.45e-02 | 1.00e+00 | 2.572 | 2 | 4 | 112 |
| GO:0005819 | spindle | 4.60e-02 | 1.00e+00 | 2.547 | 2 | 4 | 114 |
| GO:0014911 | positive regulation of smooth muscle cell migration | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 16 |
| GO:0048037 | cofactor binding | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 16 |
| GO:2000811 | negative regulation of anoikis | 4.70e-02 | 1.00e+00 | 4.380 | 1 | 1 | 16 |
| GO:0006006 | glucose metabolic process | 4.96e-02 | 1.00e+00 | 2.485 | 2 | 4 | 119 |
| GO:0030742 | GTP-dependent protein binding | 4.99e-02 | 1.00e+00 | 4.292 | 1 | 1 | 17 |
| GO:0071889 | 14-3-3 protein binding | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 18 |
| GO:0070064 | proline-rich region binding | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 18 |
| GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 18 |
| GO:0031954 | positive regulation of protein autophosphorylation | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 18 |
| GO:0010507 | negative regulation of autophagy | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 18 |
| GO:0090316 | positive regulation of intracellular protein transport | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 18 |
| GO:0006259 | DNA metabolic process | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0031572 | G2 DNA damage checkpoint | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0007088 | regulation of mitosis | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0045453 | bone resorption | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0031667 | response to nutrient levels | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0000070 | mitotic sister chromatid segregation | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 19 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 5.57e-02 | 1.00e+00 | 2.391 | 2 | 3 | 127 |
| GO:0007264 | small GTPase mediated signal transduction | 5.62e-02 | 1.00e+00 | 1.785 | 3 | 7 | 290 |
| GO:0032148 | activation of protein kinase B activity | 5.84e-02 | 1.00e+00 | 4.058 | 1 | 1 | 20 |
| GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 5.84e-02 | 1.00e+00 | 4.058 | 1 | 2 | 20 |
| GO:0001578 | microtubule bundle formation | 5.84e-02 | 1.00e+00 | 4.058 | 1 | 1 | 20 |
| GO:0043473 | pigmentation | 5.84e-02 | 1.00e+00 | 4.058 | 1 | 2 | 20 |
| GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 5.84e-02 | 1.00e+00 | 4.058 | 1 | 1 | 20 |
| GO:0009615 | response to virus | 5.97e-02 | 1.00e+00 | 2.335 | 2 | 4 | 132 |
| GO:0007369 | gastrulation | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:0045862 | positive regulation of proteolysis | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:0046847 | filopodium assembly | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:0000245 | spliceosomal complex assembly | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:0031648 | protein destabilization | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:0051881 | regulation of mitochondrial membrane potential | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:0000281 | mitotic cytokinesis | 6.12e-02 | 1.00e+00 | 3.987 | 1 | 1 | 21 |
| GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 6.40e-02 | 1.00e+00 | 3.920 | 1 | 1 | 22 |
| GO:0046686 | response to cadmium ion | 6.40e-02 | 1.00e+00 | 3.920 | 1 | 1 | 22 |
| GO:0001106 | RNA polymerase II transcription corepressor activity | 6.40e-02 | 1.00e+00 | 3.920 | 1 | 1 | 22 |
| GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 6.40e-02 | 1.00e+00 | 3.920 | 1 | 1 | 22 |
| GO:0006656 | phosphatidylcholine biosynthetic process | 6.40e-02 | 1.00e+00 | 3.920 | 1 | 1 | 22 |
| GO:0007052 | mitotic spindle organization | 6.40e-02 | 1.00e+00 | 3.920 | 1 | 1 | 22 |
| GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 6.69e-02 | 1.00e+00 | 3.856 | 1 | 1 | 23 |
| GO:0002040 | sprouting angiogenesis | 6.69e-02 | 1.00e+00 | 3.856 | 1 | 1 | 23 |
| GO:0051017 | actin filament bundle assembly | 6.69e-02 | 1.00e+00 | 3.856 | 1 | 1 | 23 |
| GO:0001892 | embryonic placenta development | 6.69e-02 | 1.00e+00 | 3.856 | 1 | 1 | 23 |
| GO:0008286 | insulin receptor signaling pathway | 6.95e-02 | 1.00e+00 | 2.210 | 2 | 4 | 144 |
| GO:0008135 | translation factor activity, nucleic acid binding | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 4 | 24 |
| GO:0005761 | mitochondrial ribosome | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 1 | 24 |
| GO:0007163 | establishment or maintenance of cell polarity | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 2 | 24 |
| GO:0051602 | response to electrical stimulus | 6.97e-02 | 1.00e+00 | 3.795 | 1 | 1 | 24 |
| GO:0019901 | protein kinase binding | 7.11e-02 | 1.00e+00 | 1.643 | 3 | 9 | 320 |
| GO:0006611 | protein export from nucleus | 7.25e-02 | 1.00e+00 | 3.736 | 1 | 1 | 25 |
| GO:0031519 | PcG protein complex | 7.25e-02 | 1.00e+00 | 3.736 | 1 | 1 | 25 |
| GO:0050715 | positive regulation of cytokine secretion | 7.25e-02 | 1.00e+00 | 3.736 | 1 | 1 | 25 |
| GO:0048705 | skeletal system morphogenesis | 7.25e-02 | 1.00e+00 | 3.736 | 1 | 1 | 25 |
| GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 7.29e-02 | 1.00e+00 | 2.170 | 2 | 3 | 148 |
| GO:0045859 | regulation of protein kinase activity | 7.53e-02 | 1.00e+00 | 3.679 | 1 | 1 | 26 |
| GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 7.53e-02 | 1.00e+00 | 3.679 | 1 | 1 | 26 |
| GO:0030148 | sphingolipid biosynthetic process | 7.53e-02 | 1.00e+00 | 3.679 | 1 | 1 | 26 |
| GO:0005525 | GTP binding | 7.54e-02 | 1.00e+00 | 1.607 | 3 | 6 | 328 |
| GO:0008283 | cell proliferation | 7.70e-02 | 1.00e+00 | 1.594 | 3 | 4 | 331 |
| GO:0051149 | positive regulation of muscle cell differentiation | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 2 | 27 |
| GO:0032720 | negative regulation of tumor necrosis factor production | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 1 | 27 |
| GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 1 | 27 |
| GO:0031424 | keratinization | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 1 | 27 |
| GO:0001103 | RNA polymerase II repressing transcription factor binding | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 1 | 27 |
| GO:0030331 | estrogen receptor binding | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 1 | 27 |
| GO:0031069 | hair follicle morphogenesis | 7.80e-02 | 1.00e+00 | 3.625 | 1 | 1 | 27 |
| GO:0010008 | endosome membrane | 8.06e-02 | 1.00e+00 | 2.085 | 2 | 2 | 157 |
| GO:0032467 | positive regulation of cytokinesis | 8.08e-02 | 1.00e+00 | 3.572 | 1 | 1 | 28 |
| GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 8.08e-02 | 1.00e+00 | 3.572 | 1 | 1 | 28 |
| GO:0005813 | centrosome | 8.14e-02 | 1.00e+00 | 1.560 | 3 | 9 | 339 |
| GO:0019005 | SCF ubiquitin ligase complex | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 1 | 29 |
| GO:0034605 | cellular response to heat | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 1 | 29 |
| GO:0072686 | mitotic spindle | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 1 | 29 |
| GO:0046875 | ephrin receptor binding | 8.63e-02 | 1.00e+00 | 3.473 | 1 | 2 | 30 |
| GO:0042169 | SH2 domain binding | 8.63e-02 | 1.00e+00 | 3.473 | 1 | 1 | 30 |
| GO:0031647 | regulation of protein stability | 8.63e-02 | 1.00e+00 | 3.473 | 1 | 1 | 30 |
| GO:0040018 | positive regulation of multicellular organism growth | 8.63e-02 | 1.00e+00 | 3.473 | 1 | 1 | 30 |
| GO:0070555 | response to interleukin-1 | 8.91e-02 | 1.00e+00 | 3.426 | 1 | 1 | 31 |
| GO:0046677 | response to antibiotic | 8.91e-02 | 1.00e+00 | 3.426 | 1 | 1 | 31 |
| GO:0007093 | mitotic cell cycle checkpoint | 8.91e-02 | 1.00e+00 | 3.426 | 1 | 2 | 31 |
| GO:0007094 | mitotic spindle assembly checkpoint | 8.91e-02 | 1.00e+00 | 3.426 | 1 | 1 | 31 |
| GO:0034220 | ion transmembrane transport | 8.96e-02 | 1.00e+00 | 1.996 | 2 | 2 | 167 |
| GO:0003723 | RNA binding | 9.05e-02 | 1.00e+00 | 1.493 | 3 | 10 | 355 |
| GO:0033572 | transferrin transport | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 1 | 32 |
| GO:0015992 | proton transport | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 1 | 32 |
| GO:0051219 | phosphoprotein binding | 9.18e-02 | 1.00e+00 | 3.380 | 1 | 4 | 32 |
| GO:0032091 | negative regulation of protein binding | 9.45e-02 | 1.00e+00 | 3.335 | 1 | 1 | 33 |
| GO:0005158 | insulin receptor binding | 9.45e-02 | 1.00e+00 | 3.335 | 1 | 2 | 33 |
| GO:0033077 | T cell differentiation in thymus | 9.45e-02 | 1.00e+00 | 3.335 | 1 | 1 | 33 |
| GO:0048812 | neuron projection morphogenesis | 9.45e-02 | 1.00e+00 | 3.335 | 1 | 1 | 33 |
| GO:0000287 | magnesium ion binding | 9.60e-02 | 1.00e+00 | 1.937 | 2 | 2 | 174 |
| GO:0001890 | placenta development | 9.73e-02 | 1.00e+00 | 3.292 | 1 | 1 | 34 |
| GO:0042692 | muscle cell differentiation | 9.73e-02 | 1.00e+00 | 3.292 | 1 | 2 | 34 |
| GO:0051701 | interaction with host | 9.73e-02 | 1.00e+00 | 3.292 | 1 | 1 | 34 |
| GO:0005876 | spindle microtubule | 9.73e-02 | 1.00e+00 | 3.292 | 1 | 1 | 34 |
| GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.250 | 1 | 1 | 35 |
| GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.00e-01 | 1.00e+00 | 3.250 | 1 | 1 | 35 |
| GO:0030178 | negative regulation of Wnt signaling pathway | 1.03e-01 | 1.00e+00 | 3.210 | 1 | 1 | 36 |
| GO:0071560 | cellular response to transforming growth factor beta stimulus | 1.03e-01 | 1.00e+00 | 3.210 | 1 | 1 | 36 |
| GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.05e-01 | 1.00e+00 | 1.856 | 2 | 5 | 184 |
| GO:0007077 | mitotic nuclear envelope disassembly | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 1 | 37 |
| GO:0018107 | peptidyl-threonine phosphorylation | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 1 | 37 |
| GO:0032880 | regulation of protein localization | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 1 | 37 |
| GO:0001568 | blood vessel development | 1.08e-01 | 1.00e+00 | 3.132 | 1 | 2 | 38 |
| GO:0050681 | androgen receptor binding | 1.08e-01 | 1.00e+00 | 3.132 | 1 | 2 | 38 |
| GO:0097191 | extrinsic apoptotic signaling pathway | 1.08e-01 | 1.00e+00 | 3.132 | 1 | 3 | 38 |
| GO:0045740 | positive regulation of DNA replication | 1.08e-01 | 1.00e+00 | 3.132 | 1 | 1 | 38 |
| GO:0090382 | phagosome maturation | 1.08e-01 | 1.00e+00 | 3.132 | 1 | 1 | 38 |
| GO:0008047 | enzyme activator activity | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 1 | 39 |
| GO:0032092 | positive regulation of protein binding | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 1 | 39 |
| GO:0042542 | response to hydrogen peroxide | 1.13e-01 | 1.00e+00 | 3.058 | 1 | 1 | 40 |
| GO:0070301 | cellular response to hydrogen peroxide | 1.16e-01 | 1.00e+00 | 3.022 | 1 | 1 | 41 |
| GO:0030521 | androgen receptor signaling pathway | 1.16e-01 | 1.00e+00 | 3.022 | 1 | 3 | 41 |
| GO:0045785 | positive regulation of cell adhesion | 1.16e-01 | 1.00e+00 | 3.022 | 1 | 1 | 41 |
| GO:0009898 | cytoplasmic side of plasma membrane | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 1 | 42 |
| GO:0042147 | retrograde transport, endosome to Golgi | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 1 | 42 |
| GO:0005902 | microvillus | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 1 | 42 |
| GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 1 | 42 |
| GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.24e-01 | 1.00e+00 | 2.920 | 1 | 1 | 44 |
| GO:0007286 | spermatid development | 1.24e-01 | 1.00e+00 | 2.920 | 1 | 1 | 44 |
| GO:0005080 | protein kinase C binding | 1.24e-01 | 1.00e+00 | 2.920 | 1 | 1 | 44 |
| GO:0034613 | cellular protein localization | 1.24e-01 | 1.00e+00 | 2.920 | 1 | 2 | 44 |
| GO:0000139 | Golgi membrane | 1.24e-01 | 1.00e+00 | 1.292 | 3 | 7 | 408 |
| GO:0009411 | response to UV | 1.27e-01 | 1.00e+00 | 2.888 | 1 | 2 | 45 |
| GO:0044297 | cell body | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 46 |
| GO:0045727 | positive regulation of translation | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 46 |
| GO:0021762 | substantia nigra development | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 2 | 46 |
| GO:0005794 | Golgi apparatus | 1.30e-01 | 1.00e+00 | 1.035 | 4 | 8 | 650 |
| GO:0043406 | positive regulation of MAP kinase activity | 1.32e-01 | 1.00e+00 | 2.825 | 1 | 1 | 47 |
| GO:0008344 | adult locomotory behavior | 1.32e-01 | 1.00e+00 | 2.825 | 1 | 2 | 47 |
| GO:0006950 | response to stress | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 1 | 48 |
| GO:0019003 | GDP binding | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 1 | 48 |
| GO:0005070 | SH3/SH2 adaptor activity | 1.37e-01 | 1.00e+00 | 2.765 | 1 | 1 | 49 |
| GO:0003743 | translation initiation factor activity | 1.37e-01 | 1.00e+00 | 2.765 | 1 | 5 | 49 |
| GO:0005765 | lysosomal membrane | 1.39e-01 | 1.00e+00 | 1.612 | 2 | 2 | 218 |
| GO:0000910 | cytokinesis | 1.42e-01 | 1.00e+00 | 2.707 | 1 | 2 | 51 |
| GO:0090263 | positive regulation of canonical Wnt signaling pathway | 1.42e-01 | 1.00e+00 | 2.707 | 1 | 1 | 51 |
| GO:0030900 | forebrain development | 1.42e-01 | 1.00e+00 | 2.707 | 1 | 1 | 51 |
| GO:0008202 | steroid metabolic process | 1.45e-01 | 1.00e+00 | 2.679 | 1 | 1 | 52 |
| GO:0030674 | protein binding, bridging | 1.45e-01 | 1.00e+00 | 2.679 | 1 | 1 | 52 |
| GO:0006952 | defense response | 1.48e-01 | 1.00e+00 | 2.652 | 1 | 1 | 53 |
| GO:0030175 | filopodium | 1.48e-01 | 1.00e+00 | 2.652 | 1 | 2 | 53 |
| GO:0009612 | response to mechanical stimulus | 1.50e-01 | 1.00e+00 | 2.625 | 1 | 1 | 54 |
| GO:0019221 | cytokine-mediated signaling pathway | 1.52e-01 | 1.00e+00 | 1.534 | 2 | 5 | 230 |
| GO:0097193 | intrinsic apoptotic signaling pathway | 1.53e-01 | 1.00e+00 | 2.598 | 1 | 2 | 55 |
| GO:0002039 | p53 binding | 1.53e-01 | 1.00e+00 | 2.598 | 1 | 1 | 55 |
| GO:0046330 | positive regulation of JNK cascade | 1.53e-01 | 1.00e+00 | 2.598 | 1 | 1 | 55 |
| GO:0008380 | RNA splicing | 1.54e-01 | 1.00e+00 | 1.522 | 2 | 5 | 232 |
| GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 1.58e-01 | 1.00e+00 | 2.547 | 1 | 1 | 57 |
| GO:0006879 | cellular iron ion homeostasis | 1.58e-01 | 1.00e+00 | 2.547 | 1 | 2 | 57 |
| GO:0005643 | nuclear pore | 1.63e-01 | 1.00e+00 | 2.497 | 1 | 1 | 59 |
| GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.68e-01 | 1.00e+00 | 2.449 | 1 | 1 | 61 |
| GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.70e-01 | 1.00e+00 | 2.426 | 1 | 1 | 62 |
| GO:0000151 | ubiquitin ligase complex | 1.73e-01 | 1.00e+00 | 2.402 | 1 | 1 | 63 |
| GO:0005901 | caveola | 1.73e-01 | 1.00e+00 | 2.402 | 1 | 1 | 63 |
| GO:0000776 | kinetochore | 1.73e-01 | 1.00e+00 | 2.402 | 1 | 3 | 63 |
| GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.73e-01 | 1.00e+00 | 2.402 | 1 | 2 | 63 |
| GO:0006417 | regulation of translation | 1.73e-01 | 1.00e+00 | 2.402 | 1 | 4 | 63 |
| GO:0032869 | cellular response to insulin stimulus | 1.75e-01 | 1.00e+00 | 2.380 | 1 | 2 | 64 |
| GO:0043025 | neuronal cell body | 1.77e-01 | 1.00e+00 | 1.391 | 2 | 5 | 254 |
| GO:0016491 | oxidoreductase activity | 1.78e-01 | 1.00e+00 | 2.357 | 1 | 1 | 65 |
| GO:0045893 | positive regulation of transcription, DNA-templated | 1.79e-01 | 1.00e+00 | 1.037 | 3 | 8 | 487 |
| GO:0004842 | ubiquitin-protein transferase activity | 1.79e-01 | 1.00e+00 | 1.380 | 2 | 3 | 256 |
| GO:0005882 | intermediate filament | 1.80e-01 | 1.00e+00 | 2.335 | 1 | 3 | 66 |
| GO:0071260 | cellular response to mechanical stimulus | 1.80e-01 | 1.00e+00 | 2.335 | 1 | 3 | 66 |
| GO:0030141 | secretory granule | 1.83e-01 | 1.00e+00 | 2.314 | 1 | 2 | 67 |
| GO:0006665 | sphingolipid metabolic process | 1.85e-01 | 1.00e+00 | 2.292 | 1 | 1 | 68 |
| GO:0006281 | DNA repair | 1.88e-01 | 1.00e+00 | 1.335 | 2 | 5 | 264 |
| GO:0035264 | multicellular organism growth | 1.90e-01 | 1.00e+00 | 2.250 | 1 | 1 | 70 |
| GO:0042393 | histone binding | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 1 | 71 |
| GO:0001503 | ossification | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 2 | 71 |
| GO:0000785 | chromatin | 1.97e-01 | 1.00e+00 | 2.190 | 1 | 2 | 73 |
| GO:0005975 | carbohydrate metabolic process | 1.99e-01 | 1.00e+00 | 1.282 | 2 | 3 | 274 |
| GO:0042826 | histone deacetylase binding | 2.00e-01 | 1.00e+00 | 2.170 | 1 | 1 | 74 |
| GO:0055085 | transmembrane transport | 2.00e-01 | 1.00e+00 | 0.959 | 3 | 3 | 514 |
| GO:0007265 | Ras protein signal transduction | 2.02e-01 | 1.00e+00 | 2.151 | 1 | 3 | 75 |
| GO:0051897 | positive regulation of protein kinase B signaling | 2.02e-01 | 1.00e+00 | 2.151 | 1 | 1 | 75 |
| GO:0060070 | canonical Wnt signaling pathway | 2.02e-01 | 1.00e+00 | 2.151 | 1 | 2 | 75 |
| GO:0046474 | glycerophospholipid biosynthetic process | 2.05e-01 | 1.00e+00 | 2.132 | 1 | 2 | 76 |
| GO:0044325 | ion channel binding | 2.07e-01 | 1.00e+00 | 2.113 | 1 | 3 | 77 |
| GO:0008584 | male gonad development | 2.07e-01 | 1.00e+00 | 2.113 | 1 | 1 | 77 |
| GO:0007229 | integrin-mediated signaling pathway | 2.09e-01 | 1.00e+00 | 2.094 | 1 | 2 | 78 |
| GO:0071013 | catalytic step 2 spliceosome | 2.12e-01 | 1.00e+00 | 2.076 | 1 | 1 | 79 |
| GO:0010629 | negative regulation of gene expression | 2.14e-01 | 1.00e+00 | 2.058 | 1 | 2 | 80 |
| GO:0019899 | enzyme binding | 2.14e-01 | 1.00e+00 | 1.210 | 2 | 5 | 288 |
| GO:0031902 | late endosome membrane | 2.14e-01 | 1.00e+00 | 2.058 | 1 | 1 | 80 |
| GO:0051301 | cell division | 2.17e-01 | 1.00e+00 | 2.040 | 1 | 2 | 81 |
| GO:0045177 | apical part of cell | 2.19e-01 | 1.00e+00 | 2.022 | 1 | 1 | 82 |
| GO:0004713 | protein tyrosine kinase activity | 2.19e-01 | 1.00e+00 | 2.022 | 1 | 1 | 82 |
| GO:0030336 | negative regulation of cell migration | 2.21e-01 | 1.00e+00 | 2.005 | 1 | 2 | 83 |
| GO:0005929 | cilium | 2.24e-01 | 1.00e+00 | 1.987 | 1 | 2 | 84 |
| GO:0005179 | hormone activity | 2.24e-01 | 1.00e+00 | 1.987 | 1 | 1 | 84 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.25e-01 | 1.00e+00 | 0.716 | 4 | 11 | 811 |
| GO:0016567 | protein ubiquitination | 2.26e-01 | 1.00e+00 | 1.156 | 2 | 3 | 299 |
| GO:0043234 | protein complex | 2.27e-01 | 1.00e+00 | 1.151 | 2 | 9 | 300 |
| GO:0042593 | glucose homeostasis | 2.35e-01 | 1.00e+00 | 1.904 | 1 | 1 | 89 |
| GO:0042384 | cilium assembly | 2.38e-01 | 1.00e+00 | 1.888 | 1 | 2 | 90 |
| GO:0016337 | single organismal cell-cell adhesion | 2.42e-01 | 1.00e+00 | 1.856 | 1 | 2 | 92 |
| GO:0042470 | melanosome | 2.42e-01 | 1.00e+00 | 1.856 | 1 | 2 | 92 |
| GO:0035335 | peptidyl-tyrosine dephosphorylation | 2.47e-01 | 1.00e+00 | 1.825 | 1 | 2 | 94 |
| GO:0005770 | late endosome | 2.47e-01 | 1.00e+00 | 1.825 | 1 | 1 | 94 |
| GO:0016310 | phosphorylation | 2.49e-01 | 1.00e+00 | 1.810 | 1 | 1 | 95 |
| GO:0007010 | cytoskeleton organization | 2.51e-01 | 1.00e+00 | 1.795 | 1 | 1 | 96 |
| GO:0005178 | integrin binding | 2.54e-01 | 1.00e+00 | 1.780 | 1 | 1 | 97 |
| GO:0007411 | axon guidance | 2.57e-01 | 1.00e+00 | 1.027 | 2 | 3 | 327 |
| GO:0016568 | chromatin modification | 2.58e-01 | 1.00e+00 | 1.750 | 1 | 2 | 99 |
| GO:0043231 | intracellular membrane-bounded organelle | 2.63e-01 | 1.00e+00 | 1.005 | 2 | 3 | 332 |
| GO:0051726 | regulation of cell cycle | 2.65e-01 | 1.00e+00 | 1.707 | 1 | 2 | 102 |
| GO:0014069 | postsynaptic density | 2.74e-01 | 1.00e+00 | 1.652 | 1 | 3 | 106 |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 2.82e-01 | 1.00e+00 | 1.598 | 1 | 1 | 110 |
| GO:0005815 | microtubule organizing center | 2.82e-01 | 1.00e+00 | 1.598 | 1 | 4 | 110 |
| GO:0050900 | leukocyte migration | 2.85e-01 | 1.00e+00 | 1.585 | 1 | 1 | 111 |
| GO:0020037 | heme binding | 2.85e-01 | 1.00e+00 | 1.585 | 1 | 1 | 111 |
| GO:0005802 | trans-Golgi network | 2.95e-01 | 1.00e+00 | 1.522 | 1 | 2 | 116 |
| GO:0032496 | response to lipopolysaccharide | 3.08e-01 | 1.00e+00 | 1.449 | 1 | 1 | 122 |
| GO:0051056 | regulation of small GTPase mediated signal transduction | 3.10e-01 | 1.00e+00 | 1.437 | 1 | 3 | 123 |
| GO:0030036 | actin cytoskeleton organization | 3.23e-01 | 1.00e+00 | 1.369 | 1 | 3 | 129 |
| GO:0046983 | protein dimerization activity | 3.27e-01 | 1.00e+00 | 1.346 | 1 | 3 | 131 |
| GO:0018108 | peptidyl-tyrosine phosphorylation | 3.31e-01 | 1.00e+00 | 1.324 | 1 | 1 | 133 |
| GO:0006644 | phospholipid metabolic process | 3.39e-01 | 1.00e+00 | 1.282 | 1 | 3 | 137 |
| GO:0016055 | Wnt signaling pathway | 3.47e-01 | 1.00e+00 | 1.240 | 1 | 3 | 141 |
| GO:0005911 | cell-cell junction | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 2 | 142 |
| GO:0016887 | ATPase activity | 3.53e-01 | 1.00e+00 | 1.210 | 1 | 1 | 144 |
| GO:0008017 | microtubule binding | 3.64e-01 | 1.00e+00 | 1.151 | 1 | 2 | 150 |
| GO:0006974 | cellular response to DNA damage stimulus | 3.80e-01 | 1.00e+00 | 1.076 | 1 | 3 | 158 |
| GO:0046777 | protein autophosphorylation | 3.80e-01 | 1.00e+00 | 1.076 | 1 | 1 | 158 |
| GO:0008022 | protein C-terminus binding | 3.85e-01 | 1.00e+00 | 1.049 | 1 | 4 | 161 |
| GO:0005739 | mitochondrion | 3.85e-01 | 1.00e+00 | 0.349 | 4 | 10 | 1046 |
| GO:0000398 | mRNA splicing, via spliceosome | 3.93e-01 | 1.00e+00 | 1.013 | 1 | 2 | 165 |
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 3.98e-01 | 1.00e+00 | 0.987 | 1 | 4 | 168 |
| GO:0006397 | mRNA processing | 4.00e-01 | 1.00e+00 | 0.979 | 1 | 3 | 169 |
| GO:0007420 | brain development | 4.05e-01 | 1.00e+00 | 0.953 | 1 | 3 | 172 |
| GO:0007596 | blood coagulation | 4.08e-01 | 1.00e+00 | 0.522 | 2 | 5 | 464 |
| GO:0016607 | nuclear speck | 4.11e-01 | 1.00e+00 | 0.929 | 1 | 2 | 175 |
| GO:0031625 | ubiquitin protein ligase binding | 4.20e-01 | 1.00e+00 | 0.888 | 1 | 4 | 180 |
| GO:0005764 | lysosome | 4.23e-01 | 1.00e+00 | 0.872 | 1 | 2 | 182 |
| GO:0001525 | angiogenesis | 4.54e-01 | 1.00e+00 | 0.736 | 1 | 3 | 200 |
| GO:0030168 | platelet activation | 4.62e-01 | 1.00e+00 | 0.700 | 1 | 4 | 205 |
| GO:0048471 | perinuclear region of cytoplasm | 4.69e-01 | 1.00e+00 | 0.349 | 2 | 9 | 523 |
| GO:0001701 | in utero embryonic development | 4.70e-01 | 1.00e+00 | 0.665 | 1 | 2 | 210 |
| GO:0004871 | signal transducer activity | 4.80e-01 | 1.00e+00 | 0.625 | 1 | 1 | 216 |
| GO:0016874 | ligase activity | 4.92e-01 | 1.00e+00 | 0.572 | 1 | 2 | 224 |
| GO:0030425 | dendrite | 5.17e-01 | 1.00e+00 | 0.473 | 1 | 3 | 240 |
| GO:0006351 | transcription, DNA-templated | 5.23e-01 | 1.00e+00 | 0.071 | 5 | 17 | 1585 |
| GO:0007165 | signal transduction | 5.49e-01 | 1.00e+00 | 0.073 | 3 | 7 | 950 |
| GO:0005783 | endoplasmic reticulum | 5.51e-01 | 1.00e+00 | 0.127 | 2 | 6 | 610 |
| GO:0005102 | receptor binding | 5.56e-01 | 1.00e+00 | 0.314 | 1 | 2 | 268 |
| GO:0000166 | nucleotide binding | 5.62e-01 | 1.00e+00 | 0.292 | 1 | 2 | 272 |
| GO:0003779 | actin binding | 5.66e-01 | 1.00e+00 | 0.276 | 1 | 3 | 275 |
| GO:0007283 | spermatogenesis | 5.67e-01 | 1.00e+00 | 0.271 | 1 | 2 | 276 |
| GO:0042493 | response to drug | 5.83e-01 | 1.00e+00 | 0.210 | 1 | 2 | 288 |
| GO:0005743 | mitochondrial inner membrane | 5.98e-01 | 1.00e+00 | 0.151 | 1 | 1 | 300 |
| GO:0006200 | ATP catabolic process | 6.01e-01 | 1.00e+00 | 0.137 | 1 | 4 | 303 |
| GO:0005856 | cytoskeleton | 6.11e-01 | 1.00e+00 | 0.099 | 1 | 6 | 311 |
| GO:0005575 | cellular_component | 6.24e-01 | 1.00e+00 | 0.049 | 1 | 2 | 322 |
| GO:0030154 | cell differentiation | 6.27e-01 | 1.00e+00 | 0.035 | 1 | 3 | 325 |
| GO:0007275 | multicellular organismal development | 6.48e-01 | 1.00e+00 | -0.047 | 1 | 2 | 344 |
| GO:0015031 | protein transport | 6.62e-01 | 1.00e+00 | -0.100 | 1 | 4 | 357 |
| GO:0008285 | negative regulation of cell proliferation | 6.72e-01 | 1.00e+00 | -0.140 | 1 | 3 | 367 |
| GO:0007155 | cell adhesion | 6.89e-01 | 1.00e+00 | -0.205 | 1 | 3 | 384 |
| GO:0045892 | negative regulation of transcription, DNA-templated | 7.25e-01 | 1.00e+00 | -0.348 | 1 | 2 | 424 |
| GO:0006366 | transcription from RNA polymerase II promoter | 7.26e-01 | 1.00e+00 | -0.352 | 1 | 3 | 425 |
| GO:0008150 | biological_process | 7.53e-01 | 1.00e+00 | -0.463 | 1 | 3 | 459 |
| GO:0055114 | oxidation-reduction process | 7.70e-01 | 1.00e+00 | -0.530 | 1 | 2 | 481 |
| GO:0005886 | plasma membrane | 7.70e-01 | 1.00e+00 | -0.282 | 7 | 24 | 2834 |
| GO:0042802 | identical protein binding | 7.77e-01 | 1.00e+00 | -0.560 | 1 | 4 | 491 |
| GO:0046872 | metal ion binding | 8.28e-01 | 1.00e+00 | -0.552 | 3 | 14 | 1465 |
| GO:0006355 | regulation of transcription, DNA-templated | 8.53e-01 | 1.00e+00 | -0.729 | 2 | 10 | 1104 |
| GO:0003700 | sequence-specific DNA binding transcription factor activity | 9.00e-01 | 1.00e+00 | -1.167 | 1 | 9 | 748 |
| GO:0003677 | DNA binding | 9.22e-01 | 1.00e+00 | -1.020 | 2 | 14 | 1351 |
| GO:0005887 | integral component of plasma membrane | 9.49e-01 | 1.00e+00 | -1.529 | 1 | 2 | 961 |
| GO:0005615 | extracellular space | 9.56e-01 | 1.00e+00 | -1.600 | 1 | 3 | 1010 |
| GO:0008270 | zinc ion binding | 9.64e-01 | 1.00e+00 | -1.680 | 1 | 7 | 1067 |